NAV
16.31(1.76%)Fund Size (CR)
₹1,468.68Expense Ratio
0.94Scheme Type
Active FundValue Research
Min. investment
₹100Minimum Additional Investment
₹100Minimum SIP Investment
₹100Minimum Withdrawal
₹100Exit Load
1%Return Since Launch
37.06%
- 3M
- 6M
- 1Y
- 3Y
- All
Basic Details
Scheme Manager
Nikhil Mathur
Bench Mark
BSE Healthcare TRI
Type
OPEN
Lumpsum Returns
| Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 26 March 2025 | 9940.45 | -0.60% | - | 0.08% | 694/860 |
| 1 Month | 28 February 2025 | 10811.58 | 8.12% | - | 6.45% | 214/856 |
| 3 Month | 2 January 2025 | 9199.24 | -8.01% | - | -8.89% | 308/820 |
| 6 Month | 1 October 2024 | 9800.04 | -2.00% | - | -12.71% | 21/749 |
| 1 Year | 2 April 2024 | 12848.55 | 28.49% | 28.49% | 5.72% | 2/660 |
| 3 Year | - | - | 0% | - | 16.28% | -/- |
| 5 Year | - | - | 0% | - | 28.05% | -/- |
| Since Inception | 4 October 2023 | 16026.00 | 60.26% | 37.06% | 10.91% | 6/860 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
| Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 2 May 2024 | 1,20,000 | 129522.70 | 7.94% | 7.94% |
| 3 Year | - | - | - | - | - |
| 5 Year | - | - | - | - | - |
| 10 Year | - | - | - | - | - |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
- Investment type
- Scheme based
- SIP
- Lumpsum
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
5.35%
Standard Deviation
0.87%
Beta
1.68%
Sharpe Ratio
0.17%
Treynor's Ratio
23.81%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
| Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
|---|---|---|---|---|---|
| Sun Pharma.Inds. | 11.99% | 1105134 | 176.08 | Equity | Pharmaceuticals |
| Divi's Lab. | 8.91% | 238910 | 130.93 | Equity | Pharmaceuticals |
| Cipla | 7.80% | 814343 | 114.62 | Equity | Pharmaceuticals |
| Lupin | 5.57% | 429469 | 81.80 | Equity | Pharmaceuticals |
| Max Healthcare | 4.87% | 731315 | 71.53 | Equity | Healthcare |
| Torrent Pharma. | 3.69% | 183598 | 54.13 | Equity | Pharmaceuticals |
| Krishna Institu. | 3.66% | 1032676 | 53.81 | Equity | Healthcare |
| Aurobindo Pharma | 3.34% | 463266 | 49.03 | Equity | Pharmaceuticals |
| Aster DM Health. | 3.28% | 1195015 | 48.15 | Equity | Healthcare |
| Ipca Labs. | 3.27% | 354644 | 48.07 | Equity | Pharmaceuticals |
Peer Comparison
| Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| HDFC Pharma and Healthcare Fund - Direct (IDCW) | 1468.68 | 8.12% | -8.01% | -2.00% | 28.49% | - | |
| HDFC Pharma and Healthcare Fund - Direct (G) | 1468.68 | 8.12% | -8.01% | -2.00% | 28.49% | - | |
| HDFC Pharma and Healthcare Fund - Direct (IDCW) | 1468.68 | 8.12% | -8.01% | -2.00% | 28.49% | - | |
| WhiteOak Capital Pharma and Healthcare Fund-Dir (G) | 271.36 | 7.68% | -8.89% | -2.42% | 27.30% | - | |
| DSP Banking & Financial Services Fund - Dir (G) | 1012.79 | 6.89% | 1.44% | -1.98% | 21.85% | - | |
| DSP Banking & Financial Services Fund - Dir (IDCW) | 1012.79 | 6.35% | 0.93% | -2.48% | 21.23% | - |
List of Schemes under HDFC Mutual Fund
News
HDFC MF announces change in Fund Manager of the following schemes
HDFC Mutual Fund has announced change in Fund Manager of the following scheme with effect from: 29 March 2025Change in Fund Manager of the Scheme:
Name of the Scheme(s) Existing Fund Manager(s) Revised Fund Manager(s) HDFC Arbitrage Fund* Nirman Morakhia and Arun Agarwal (Arbitrage Assets),
Anil Bamboli (Debt Assets)Nandita Menezes and Arun Agarwal (Arbitrage Assets),
Anil Bamboli (Debt Assets)HDFC Balanced Advantage Fund* Gopal Agarwal and
Srinivasan Ramamurthy
(Equity Assets), Nirman Morakhia and Arun Agarwal (Arbitrage Assets),
Anil Bamboli (Debt Assets)Gopal Agarwal and Srinivasan Ramamurthy
(Equity Assets), Nandita Menezes and Arun Agarwal (Arbitrage Assets),
Anil Bamboli (Debt Assets)HDFC Equity Savings Fund* Srinivasan Ramamurthy (Equity Assets),
Anil Bamboli (Debt Assets)
Nirman Morakhia and Arun Agarwal (Arbitrage Assets)Srinivasan Ramamurthy (Equity Assets),
Anil Bamboli (Debt Assets),
Nandita Menezes and Arun Agarwal (Arbitrage Assets)HDFC Multi-Asset Fund* Srinivasan Ramamurthy (Equity Assets),
Anil Bamboli (Debt Assets),
Bhagyesh Kagalkar (Gold Assets),
Nirman Morakhia and Arun Agarwal (Arbitrage Assets)Srinivasan Ramamurthy (Equity Assets),
Anil Bamboli (Debt Assets),
Bhagyesh Kagalkar (Gold Assets),
Nandita Menezes and Arun Agarwal (Arbitrage Assets)HDFC BSE 500 Index Fund HDFC BSE Sensex Index Fund
HDFC Developed World Indexes Fund of Funds
HDFC Gold ETF Fund of Fund
HDFC Nifty 100 Index Fund
HDFC Nifty 50 Index Fund
HDFC Nifty India Digital Index Fund
HDFC Nifty LargeMidcap 250 Index Fund
HDFC NIFTY Midcap 150 Index Fund
HDFC Nifty Next 50 Index Fund
HDFC NIFTY Realty Index Fund
HDFC Nifty Smallcap 250 Index Fund
HDFC Nifty Top 20 Equal Weight Index Fund
HDFC Nifty100 Equal Weight Index Fund
HDFC NIFTY100 Low Volatility 30 Index Fund
HDFC Nifty100 Quality 30 Index Fund
HDFC NIFTY200 Momentum 30 Index Fund
HDFC NIFTY50 Equal Weight Index Fund
HDFC Nifty500 Multicap 50:25:25 Index Fund
Nirman Morakhia and Arun Agarwal Nandita Menezes and Arun Agarwal HDFC Retirement Savings Fund (Equity Plan, Hybrid Equity Plan and Hybrid Debt Plan) Srinivasan Ramamurthy (Equity Portfolio), Shobhit Mehrotra (Debt Portfolio), Dhruv Muchhal (Dedicated Fund Manager for Overseas Investments) Srinivasan Ramamurthy (Equity Assets), Shobhit Mehrotra (Debt Assets), Nandita Menezes and Arun Agarwal (Arbitrage Assets) Dhruv Muchhal (Dedicated Fund Manager for Overseas Investments) HDFC BSE 500 ETF HDFC NIFTY Midcap 150 ETF
HDFC Nifty Smallcap 250 ETF
Abhishek Mor, Nirman Morakhia and Arun Agarwal Abhishek Mor, Nandita Menezes and Arun Agarwal *Dhruv Muchhal (Dedicated Fund Manager for Overseas Investments)
Powered by Capital Market - Live News
HDFC MF announces change in fund manager under its scheme
HDFC Mutual Fund has announced change in fund manager under the following schemes, with effect from 20 March 2025.Change in Fund Manager:
Name of the Scheme Existing Fund Manager(s) Revised Fund Manager HDFC Income Plus Arbitrage Active FOF Fund Manager: Mr. Srinivasan Ramamurthy
Co-Fund Manager: Mr. Anil BamboliMr. Anil Bamboli Powered by Capital Market - Live News
HDFC MF announces Income Distribution cum Capital Withdrawal (IDCW) under under its scheme
HDFC Mutual Fund has announced 20 March 2025 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) on the face value of Rs 10 per unit under the regular plan IDCW & monthly IDCW option and direct plan IDCW & monthly IDCW option of HDFC Arbitrage Fund. The amount of distribution (Rs per unit) will be:HDFC Arbitrage Fund ' Wholesale Plan ' Regular Plan ' Normal IDCW Option (Payout & Reinvestment): 0.050
HDFC Arbitrage Fund ' Wholesale Plan ' Direct Plan ' Normal IDCW Option (Payout & Reinvestment): 0.050
HDFC Arbitrage Fund ' Wholesale Plan ' Regular Plan ' Monthly IDCW Option (Payout & Reinvestment): 0.050
HDFC Arbitrage Fund ' Wholesale Plan ' Direct Plan ' Monthly IDCW Option (Payout & Reinvestment): 0.050
Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
14 September 2023
Total AUM (Cr)
₹1468.68
HDFC Pharma and Healthcare Fund - Direct (IDCW) is an Sectoral / Thematic-oriented fund from the renowned AMC, HDFC Mutual Fund. Launched in 14 September 2023, this fund is managed by Nikhil Mathur. With assets under management (AUM) worth ₹1,468.68 (Cr), as of 3 April 2025, HDFC Pharma and Healthcare Fund - Direct (IDCW) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 37.06% since its launch.
The current NAV of HDFC Pharma and Healthcare Fund - Direct (IDCW) is ₹16.31, as on 3 April 2025. The fund's benchmark index is BSE Healthcare TRI. You can invest in HDFC Pharma and Healthcare Fund - Direct (IDCW) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹100 while the minimum lumpsum investment is ₹100.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
In respect of each purchase/Switch-in of units, an Exit load of 1% is payable if units are redeemed/switched-out within 30 days from the date of allotment. No Exit Load is payable if units are redeemed / switched-out after 30 days from the date of allotment. The fund has generated undefined% and undefined% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 97.46% in Equity, 1.13% in Debt and 1.41% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 73.62% in Pharmaceuticals & Biotech, 21.21% in Healthcare Services, 1.57% in Others, 1.49% in Healthcare Equipment & Su, 1.14% in Insurance
FAQs
How to Invest in HDFC Pharma and Healthcare Fund - Direct (IDCW) Direct Growth?
HDFC Pharma and Healthcare Fund - Direct (IDCW) is a popular fund in the Sectoral / Thematic segment. The fund has generated a return of 37.06% since inception. Looking to invest in HDFC Pharma and Healthcare Fund - Direct (IDCW) How about earning 1% extra return? All this is possible with m.Stock! Investing in HDFC Pharma and Healthcare Fund - Direct (IDCW) is super easy and convenient with m.Stock. Here’s how you can begin:
- Login to your m.Stock account. If you do not have an account, open m.Stock Demat account and enjoy 1% extra returns plus Zero Brokerage on Mutual Funds, Delivery & IPO.
- In the ‘Menu’ section, under ‘Products’, select ‘Mutual Funds’ .
- In the search bar, enter the fund name, in this case, HDFC Pharma and Healthcare Fund - Direct (IDCW)
- On the top right corner you’ll see two options – Lumpsum and SIP. You can choose either based on your risk appetite and available investible corpus.
- If you choose to invest a Lumpsum: Use the Lumpsum Calculator to estimate returns, then enter the investment amount, select the payment mode mode (UPI or Netbanking), and click on ‘invest a lumpsum’. Make the payment and your lumpsum investment is complete.
- If you choose the SIP route: Utilize the SIP Calculator to forecast potential growth, then enter the SIP amount, SIP date, and set up ‘Autopay’ facility.
So, why wait? Invest in HDFC Pharma and Healthcare Fund - Direct (IDCW) today and reap the benefits of this Sectoral / Thematic fund!
How much returns has HDFC Pharma and Healthcare Fund - Direct (IDCW) Direct Growth generated?
What is the expense ratio of HDFC Pharma and Healthcare Fund - Direct (IDCW) Direct Growth?
What is the AUM of HDFC Pharma and Healthcare Fund - Direct (IDCW) Fund Direct Growth?
How to redeem or withdraw money from HDFC Pharma and Healthcare Fund - Direct (IDCW) Direct Growth?
Redeeming or selling units of HDFC Pharma and Healthcare Fund - Direct (IDCW) is relatively simple. But before you redeem, ensure that the fund has completed the minimum lock-in period else you will be charged an exit load.
To redeem from HDFC Pharma and Healthcare Fund - Direct (IDCW):
- Login to your m.Stock account
- In portfolio, your mutual fund investments will be visible under ‘MF’
- Select the fund you wish to redeem from (in this case HDFC Pharma and Healthcare Fund - Direct (IDCW)).
- Click on ‘Redeem’ button
- You have 2 options – redeem by units and redeem by value (you can only redeem free units)
- Select units to be redeemed and click on submit.
- Redemption value will be credited to your account in 2-3 working days (as per timelines set by SEBI).